Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders

Author:

Lotfi Abeya A1,Mohamed Asmaa E1,Shalaby Nahela A2,Eissa Deena S2,El-Dabaa Ehab3,Sallam Ayman M3,Kamel Mahmoud M4ORCID,Abdelaziz Hisham4,El-Afifi Amal M5,Abdel-Moneim Ahmed S67

Affiliation:

1. Clinical and Chemical Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt

2. Clinical and Chemical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

3. Biochemistry and Molecular biology department, Theodor Bilharz Research Institute, Giza, Egypt

4. Clinical Pathology Department, National Cancer Institute, Cairo University, Giza, Egypt

5. Department of Clinical hematology and transplantation, Ain shams University, Cairo, Egypt

6. Microbiology Department, College of Medicine, Taif University, Taif, Saudi Arabia

7. Virology Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt

Abstract

Despite the link between HCV and malignant lymphoproliferative disorders has been established, the association between occult hepatitis C virus infection and malignant lymphoproliferative disorders remains obscure. The present study intended to identify the possible association between occult HCV infection and malignant lymphoproliferative disorders. Newly diagnosed patients with LPDs were screened for the presence of HCV-RNA in both plasma and PBMCs. PBMCs of the subjects were also, examined by transmission and immuno-electron microscopy. LPD patients showed a high percentage of HCV infection (71.9%): OCI-HCV (37.5%) and HCV (34.38%). Meanwhile, 28.13% of LPD patients did not show any evidence of HCV infection. Ultrastructural examination of PBMCs revealed the presence of intracytoplasmic vacuoles enclosing viral like particles, which were less prominent in occult HCV patients. The possibility of occult HCV should be considered in patients with LPDs which can be helpful in the management of the treatment protocol in order to set up a balance between the control of the tumor progression and minimizing post chemotherapy complications related to HCV infection.

Funder

taif university

Theodor Bilharz Research Institute

Publisher

SAGE Publications

Subject

Pharmacology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3